Rocket Lab CEO Says Demand Is 'Super Healthy' As Defense, Neutron Backlog Builds

Benzinga
Yesterday

Rocket Lab Corp. (NASDAQ:RKLB) executives pointed to accelerating launch demand, expanding defense work and progress on the company's Neutron rocket as key drivers of momentum following a record first quarter.

  • RKLB stock is climbing. See the chart and price action here. 

Rocket Lab's $2.2B Backlog 

"Our backlog jumped to more than $2 billion in contracted revenue across our national security, civil space, and commercial programs, 20% over the quarter and 108% year-over-year," CEO Peter Beck said on the company's Thursday evening earnings call. 

Beck said the record backlog was supported by strong contract activity across Rocket Lab's launch portfolio. The company signed 31 Electron and HASTE launch contracts during the quarter, along with five Neutron contracts.

Read Also: The Trade Desk Stock Tumbles After Q1 Earnings Miss Estimates

"With the 31 Electron and HASTE launches and 5 Neutron contracts combined, we’ve booked more launches in the first three months of 2026 than we did for all of last year," Beck said.

CFO Adam Spice added that Rocket Lab ended the quarter with approximately $2.2 billion in total backlog. Launch backlog accounted for about 41.5% of the total, while space systems represented the remaining 58.5%.

"During the quarter, launch backlog continued to gain share, supported by strong underlying trends as we convert a robust pipeline of opportunities across Electron, HASTE, and Neutron," Spice said.

Growing Defense Role

Management also emphasized Rocket Lab's growing role in defense and national security programs. 

Beck said the company's HASTE program is delivering "critical hypersonic test launch capability to the Department of Defense."

Rocket Lab recently secured a $190 million, 20-launch HASTE order through Kratos Defense & Security Solutions (NASDAQ:KTOS) and the DOD's MACH-TB program. 

Beck called the award "a very clear vote of confidence from the Pentagon in HASTE’s ability to deliver the hypersonic test and missile defense capabilities that the nation needs."

The company is also supporting the Space-Based Interceptor program under Golden Dome in partnership with RTX Corp. (NYSE:RTX), which Beck described as one of the nation's top national security priorities.

Neutron Updates

Alongside defense momentum, Rocket Lab continues to advance Neutron, its medium-lift rocket designed for constellation deployment and national security missions. 

Beck said the program remains on track for a first launch later this year, citing progress on tank refinements, stage-separation tests, Archimedes engine hot fires and landing barge work.

"Current progress is keeping our aggressive schedule towards the first launch later this year," Beck said.

When asked about customer reception for Neutron, Beck said demand is not a concern.

"Demand is just not one of [the things I worry about]," Beck said. "The backlog is super healthy for a number of years."

Read Also: AMD Stock Gets A Racehorse-Sized Bull Call From Jim Cramer

Looking Ahead

Rocket Lab guided for second-quarter revenue of $225 million to $240 million and an adjusted EBITDA loss of $20 million to $26 million. 

With launch demand building, defense work expanding and Neutron moving closer to debut, management positioned Rocket Lab's record quarter as part of a broader growth phase rather than a one-time step-up.

RKLB Price Action: Rocket Lab stock was up 13.01% at $88.80 at the time of publication on Friday, according to Benzinga Pro.

Over the past month, RKLB has gained about 23.3% versus a 8.7% rise in the S&P 500 and is up roughly 26% year-to-date compared to the index’s 7.2% gain.

Photo courtesy of Rocket Lab Corp.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10